Dermal Filler Market Analysis

  • Report ID: 2275
  • Published Date: Sep 08, 2025
  • Report Format: PDF, PPT

Dermal Filler Market Segmentation:

Materials Segment Analysis

Based on materials, the calcium hydroxylapatite segment is anticipated to capture the largest share in the dermal filler market by 2035. Its dominance is attributable to the widespread use of soft tissue fillers for aesthetic restoration, coupled with an increase in procedures involving this regimen. On this note, a worldwide survey was conducted by the International Society of Aesthetic Plastic Surgery (ISAPS) in 2022 on cosmetic procedures. The results revealed that the global number of procedures involving calcium hydroxylapatite was 350,716 in 2022, increasing by 20.9% from 2021 and 171.8% from 2018. These figures testify to the segment’s proprietorship over other types of filler materials.

Product Segment Analysis

In terms of product, the non-biodegradable segment is gaining traction in the dermal filler market and is expected to garner notable revenue over the assessed period. This segment is becoming a first-line preference for candidates seeking natural-looking results, stimulation of collagen production, and controlled degeneration. In addition, the manufacturers are also setting their goals in attaining maximum sustainability in their pipeline, making these products more popular across the globe. For instance, in 2022, hyaluronic acid-based filling was the 2nd most performed non-surgical aesthetic procedure in the world, accounting for 4,312,037, up by 15.6% from 2018 (ISAPS survey).

Our in-depth analysis of the global dermal filler market includes the following segments: 

Materials

  • Calcium Hydroxylapatite
  • Hyaluronic Acid
  • Poly-L-lactic Acid
  • PMMA [Poly Methyl Methacrylate]
  • Fat
  • Others

Product

  • Biodegradable
  • Non-Biodegradable

Application

  • Lip Enhancement
  • Wrinkle Correction Treatment
  • Face-Lift
  • Scar Treatment
  • Others

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of dermal filler is assessed at USD 6.43 billion.

The global dermal filler market size was valued at more than USD 5.92 billion in 2025 and is expected to register a CAGR of over 9.5%, exceeding USD 14.67 billion revenue by 2035.

North America dermal filler market is poised to capture 38.8% share by 2035, driven by high cosmetic procedure rates and R&D investments.

Key players in the market include Allergen, Merz Pharma, Sinclair Pharma, Galderma Laboratories, BioPlus Co., Ltd., Candela Corporation, BIOXIS pharmaceuticals, Suneva Medical, SCULPT Luxury Dermal Fillers Ltd, Dr. Korman Laboratories Ltd.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos